Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?

The neuroradiology journal - 1 Oct 2017

Rabelo Ana Gb, Teixeira Camila Vl, Magalhães Thamires Nc, Carletti-Cassani Ana Flávia Mk, Amato Filho Augusto Cs, Joaquim Helena Pg, Talib Leda L, Forlenza Orestes, Ribeiro Patrícia Ao, Secolin Rodrigo, Lopes-Cendes Iscia, Cendes Fernando, Balthazar Marcio Lf

Abstract excerpt

Introduction The search for a reliable neuroimaging biomarker in Alzheimer's disease is a matter of intense research. The presence of cerebral microbleeds seems to be a potential biomarker. However, it is not clear if the presence of microbleeds has clinical usefulness to differentiate mild Alzheimer's disease and amnestic mild cognitive impairment from normal aging. We aimed to verify if microbleed prevalence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Amyloid beta-Peptides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Cerebral Hemorrhage

Share to Cognitive Dysfunction

Share to Magnetic Resonance Imaging

Share to Neuropsychological Tests

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 28714354
DOI: 10.1177/1971400917720465
PMCID: PMC5602341

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?PMID 28714354Read ↗

Cerebral Microbleeds as a Biomarker in Alzheimer’S Disease? A Review in The FieldSemantic proximity Read ↗

The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals.Semantic proximity Read ↗

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.Semantic proximity Read ↗

Genetic associations with brain microbleeds: Systematic review and meta-analyses.Semantic proximity Read ↗

Isolated medial temporal lobe amnesia (MTLA): Predictor of cerebral amyloidosis or marker of phenotype-specific vulnerability?Semantic proximity Read ↗

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.Semantic proximity Read ↗

Apolipoprotein E genotype influences spatial distribution of cerebral microbleeds.Semantic proximity Read ↗

[Clinical relevance of cerebral microbleeds--update].Semantic proximity Read ↗

Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type.Semantic proximity Read ↗

Association of common genetic variants with brain microbleeds: A genome-wide association study.Semantic proximity Read ↗

Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location.Semantic proximity Read ↗

Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.